Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 5
Submit an article Journal homepage
760
Views
13
CrossRef citations to date
0
Altmetric
Author's View

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells

Jean-François Fonteneau INSERM; UMR892; Nantes, France; CNRS; UMR6299; Nantes, France; Université de Nantes; Nantes, FranceCorrespondence[email protected]
,
Jean-Baptiste Guillerme INSERM; UMR892; Nantes, France; CNRS; UMR6299; Nantes, France; Université de Nantes; Nantes, France
,
Frédéric Tangy CNRS; URA3015; Institut Pasteur; Unité de Génomique Virale et Vaccination; Paris, France
&
Marc Grégoire INSERM; UMR892; Nantes, France; CNRS; UMR6299; Nantes, France; Université de Nantes; Nantes, France
Article: e24212 | Received 01 Mar 2013, Accepted 06 Mar 2013, Published online: 01 May 2013

References

  • Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol 2012; 30:658 - 70; http://dx.doi.org/10.1038/nbt.2287; PMID: 22781695
  • Guillerme JB, Grégoire M, Tangy F, Fonteneau JF. Antitumor virotherapy by attenuated measles virus (MV). Biology 2013; 2:587 - 602; http://dx.doi.org/10.3390/biology2020587
  • Anderson BD, Nakamura T, Russell SJ, Peng KW. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 2004; 64:4919 - 26; http://dx.doi.org/10.1158/0008-5472.CAN-04-0884; PMID: 15256464
  • Fishelson Z, Donin N, Zell S, Schultz S, Kirschfink M. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol Immunol 2003; 40:109 - 23; http://dx.doi.org/10.1016/S0161-5890(03)00112-3; PMID: 12914817
  • Gauvrit A, Brandler S, Sapede-Peroz C, Boisgerault N, Tangy F, Gregoire M. Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response. Cancer Res 2008; 68:4882 - 92; http://dx.doi.org/10.1158/0008-5472.CAN-07-6265; PMID: 18559536
  • Donnelly OG, Errington-Mais F, Steele L, Hadac E, Jennings V, Scott K, et al. Measles virus causes immunogenic cell death in human melanoma. Gene Ther 2013; 20:7 - 15; http://dx.doi.org/10.1038/gt.2011.205; PMID: 22170342
  • Guillerme JB, Boisgerault N, Roulois D, Ménager J, Combredet C, Tangy F, et al. Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells. Clin Cancer Res 2013; 19:1147 - 58; http://dx.doi.org/10.1158/1078-0432.CCR-12-2733; PMID: 23339127
  • Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8:594 - 606; http://dx.doi.org/10.1038/nri2358; PMID: 18641647
  • Tel J, van der Leun AM, Figdor CG, Torensma R, de Vries IJ. Harnessing human plasmacytoid dendritic cells as professional APCs. Cancer Immunol Immunother 2012; 61:1279 - 88; http://dx.doi.org/10.1007/s00262-012-1210-z; PMID: 22294456
  • Aricò E, Belardelli F. Interferon-α as antiviral and antitumor vaccine adjuvants: mechanisms of action and response signature. J Interferon Cytokine Res 2012; 32:235 - 47; http://dx.doi.org/10.1089/jir.2011.0077; PMID: 22490303

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.